Navigating the area of terminal care and access to medications like this drug in New South Wales, the state, requires a careful understanding of the detailed legal system. Currently, this powerful sedative does not have a approved place on the Pharmaceutical Benefits Scheme (PBS) and is therefore not routinely prescribed by healthcare professionals